Register entry
Chaks Cosmetic Design Services Pte Ltd
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- Singapore
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1Relabelling1Repackaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| CHAKS COSMETIC DESIGN & SERVICES PTE LTDRegistrant: Chaks Cosmetic Design Services Pte Ltd | 25 KALLANG AVENUE #05-01, Singapore, 339416, Singapore (SGP) | Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging | 3006275917595557596 |
Neighbours
Registered in the same town
12- Merck & Co., Inc.Singapore, SGP · 5 sites
- SanofiSingapore, SGP · 2 sites
- Novartis Pharmaceuticals CorporationSingapore, SGP
- Baxalta US Inc.Singapore, SGP
- Charles River Laboratories, Inc.Singapore, SGP
- Lonza Biologics IncSingapore, SGP
- AbbVie Inc.Singapore, SGP
- Pfizer IncSingapore, SGP
- Amgen, IncSingapore, SGP
- Genentech, Inc.Singapore, SGP
- Almac Pharma Services (Ireland) LimitedSingapore, SGP
- Austrianova (Thailand) Company LimitedSingapore, SGP
Compare
Comparable companies in Singapore
- Borden Company (Private) Limited1 site · 21 NDC
- Haw Par Healthcare Ltd.1 site · 18 NDC
- FEI FAH MEDICAL MANUFACTURING PTE LTD1 site · 1 NDC
- LEUNG KAI FOOK MEDICAL CO PTE LTD1 site · 1 NDC
- NING PTE LTD1 site · 1 NDC
- Austrianova (Thailand) Company Limited2 sites · 0 NDC
Enquiry
Common questions
- Is Chaks Cosmetic Design Services Pte Ltd FDA approved?
- Chaks Cosmetic Design Services Pte Ltd holds 1 FDA-registered establishment in Singapore. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Chaks Cosmetic Design Services Pte Ltd's drugs manufactured?
- The FDA register lists Singapore. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, relabelling, repackaging.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.